Recce Pharmaceuticals Ltd (RCE) — Capital Reinvestment Ratio
Latest as of June 2014:
3.08x
Recce Pharmaceuticals Ltd (RCE) has a Capital Reinvestment Ratio of 3.08x as of June 2014, meaning it reinvests 3% of its operating cash flow (AU$11.43K) in capital expenditures (AU$35.25K). See Recce Pharmaceuticals Ltd free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
3.08x
Capex / Operating Cash Flow
Operating Cash Flow
AU$11.43K
AUD
Capital Expenditures
AU$35.25K
AUD
Data as of
Jun 2014
Most recent filing
Recce Pharmaceuticals Ltd Capital Reinvestment Ratio (2014–2014)
This chart tracks Recce Pharmaceuticals Ltd's Capital Reinvestment Ratio across 1 annual periods.
Annual Capital Reinvestment Ratio for Recce Pharmaceuticals Ltd (2014–2014)
Year-by-year Capital Reinvestment Ratio for Recce Pharmaceuticals Ltd from 2014 to 2014. For live market cap and broader valuation context, see Recce Pharmaceuticals Ltd market cap and net worth.
| Year | Reinvestment Ratio | Operating CF (AUD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2014 | 3.08x | AU$11.43K | AU$35.25K | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow